Abstract
Prader-Willi syndrome (PWS) is a complex neurogenetic disorder resulting from a silencing of paternally contributed genes on chromosome #15 – q11.2–q13 – with an estimated incidence of 1/10,000–1/25,000 live births. The clinical phenotype and course of the disorder vary over time. Infancy and early childhood are characterized by infantile hypotonia, often accompanied by feeding difficulties and failure to thrive, an abnormal body composition including a markedly reduced muscle mass, facial and body dysmorphisms, hypogonadism, and developmental issues. Between 2 and 3 years of age, significant changes in fat distribution precede an abnormally escalating food intake that can result in morbid, occasionally life-threatening obesity coupled with short stature and endocrinopathies. Cognitive impairments and characteristic learning difficulties become evident in early childhood, accompanied by emergent behavior difficulties that increase across time, with a particular escalation noted in early adolescence.
Sleep-disordered breathing is present across the life span with both reduced arousal responses and central apneas occurring more frequently in infants and excessive daytime sleepiness among those school-aged and older. Independent of weight status, central sleep issues may be accompanied by obstructive apnea. All sleep issues are worsened in the context of obesity or enlarged tonsils and adenoids. This chapter reviews the multiple sources and management of disordered sleep and sleep-disordered breathing in this population.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Prader A, Labhart A, Willi H. Ein Syndrom von Adipositas, Kleinwuchs, Kryptorchismus und Oligophrenie nach myatonieartigem Zustand im Neugeborenalter. Schweiz Med Wochenschr. 1956;86:1260–1.
Donaldson MDC, Chu CE, Cooke A, et al. The Prader-Willi syndrome. Arch Dis Child. 1994;70:58–63.
Tuysuz B, Erener-Ercan T, Guclu-Geyik F, et al. Prevalence of Prader-Willi syndrome among infants with hypotonia. J Pediatr. 2014;164(5):1064–7.
Cassidy SB, Schwartz S, Miller J, Driscoll DJ. Prader-Willi syndrome. Genet Med. 2012;14:10–26.
Khayat A, Narang I, Bin-Hasan S, et al. Longitudinal evaluation of sleep disordered breathing in infants with Prader-Willi syndrome. Arch Dis Child. 2017;102(7):638–42.
Chen M, Hamilton J, Narang I. Clinically important age-related differences in sleep disordered breathing in infants and children with Prader-Willi syndrome. PLoS One. 2014;9(6):e101012.
Miller JL, Lynn CH, Driscoll DC, Goldstone AP, et al. Nutritional phases in Prader-Willi syndrome. Am J Med Genet A. 2011;155:1040–9.
Dykens EM, Cassidy SB, King BH. Maladaptive behavior differences in Prader-Willi syndrome due to paternal deletion vs maternal uniparental disomy. Am J Ment Retar. 1999;104:67–77.
Butler J, Whittington J, Holland A, et al. Prevalence of and risk factors for physical health in people with Prader-Willi syndrome: a population based study. Dev Med Child Neurol. 2001;44:248–55.
Einfeld S, Kavanaugh S, Smith A, et al. Mortality in Prader-Willi syndrome. Am J Men Retard. 2006;111:193–8.
Marcus CL, Brooks LJ, Ward SD, et al. Technical report: diagnosis and management of childhood obstructive sleep apnea. Pediatrics. 2012;130(3):e714–55.
Aurora RN, Zak RS, Karippot A, et al. Practice parameters for the respiratory indications for polysomnography in children. Sleep. 2011;34(3):379–88.
American Academy of Pediatrics, Section on Pediatric Pulmonology, Subcommittee on Obstructive Sleep Apnea Syndrome. Clinical practice guideline: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2002;109:704–12.
Holm VA, Cassidy SB, Butler MG, et al. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics. 1993;91:398–402.
Hertz G, Cataletto M, Feinsilver SH, Angulo M. Sleep and breathing patterns in patients with Prader-Willi syndrome (PWS): effects of age and gender. Sleep. 1993;16:366–71.
Vgontzas AN, Kales A, Seip J, Mascari MU, et al. Relationship of sleep abnormalities to patient genotypes in Prader-Willi syndrome. Am J Med Genet. 1996;67:478–82.
Sedky K, Bennett DS, Pumariega A. Prader-Willi syndrome and obstructive sleep apnea: co-occurrence in the pediatric population. J Clin Sleep Med. 2014;10:403–9.
Bixler ED, Vgontzas AN, Li HM, et al. Sleep disordered breathing in children in a general population sample and risk factors. Sleep. 2009;32(6):731–8.
Pavone M, Caldarelli V, Khirani S, et al. Sleep disordered breathing in patients with Prader-Willi syndrome: a multicenter study. Pediatr Pulmonol. 2015;50(12):1354–9.
Williams K, Scheimann A, Sutton V, et al. Sleepiness and sleep disordered breathing in Prader-Willi syndrome: relationship to genotype, growth hormone therapy and body composition. J Clin Sleep Med. 2007;4(2):111–8.
Cohen M, Hamilton J, Narang I. Clinically important age-related differences in sleep related disordered breathing in infants and children with Prader-Willi syndrome. PLoS One. 2014;9(6):e101012.
Menendez AA. Abnormal ventilatory responses in patients with Prader Willi syndrome. Eur J Pediatr. 1999;158(11):941–2.
Lindgren AC, Hellstrom LG, Ritzen EM, et al. Growth hormone treatment increases CO2 response, ventilation and central inspiratory drive in children with Prader-Willi syndrome. Eur J Pediatr. 1999;158(11):936–40.
Gozal D, Arens R, Omlin KJ, et al. Absent peripheral chemo-sensitivity in Prader-Willi syndrome. J Appl Physiol. 1994;77(5):2231–6.
Marcus CL, Brooks LJ, Draper KA, et al. Clinical practice guideline: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012;130(3):576–84.
Katz ES, Marcus CL. Diagnosis of obstructive sleep apnea. In: Sheldon SH, Ferber R, Kryger MH, editors. Principles and practice of pediatric sleep medicine, vol. 227. 2nd ed. New York: Elsevier-Saunders; 2015, Table 28.4.
Spruyt K, Gozal D. Pediatric sleep questionnaires as diagnostic or epidemiological tools: a review of currently available instruments. Sleep Med Rev. 2011;15(1):19–32.
Costa DJ, Mitchell R. Adenotonsillectomy for obstructive sleep apnea in obese children: a meta-analysis. Otolaryngol Head Neck Surg. 2009;140(4):455–60.
DeLuca Canto G, Pacheco-Pereira C, Aydinoz S, et al. Adenotonsillectomy complications: a meta-analysis. Pediatrics. 2015;136(4):702–18.
Pavone M, Paglietti M, Petrone A, et al. Adenotonsillectomy for obstructive sleep apnea in children with Prader-Willi syndrome. Pediatr Pulmonol. 2006;41:74–9.
Patino M, Sadhasivam S, Mahmoud M. Obstructive sleep apneoa in children: perioperative considerations. Br J Anesth. 2013;111(S1):183–95.
Crockett DJ, Ahmed SR, Sowder DR, et al. Velopharyngeal dysfunction in children with Prader-Willi syndrome after adenotonsillectomy. Int J Pediatr Otorhinolaryngol. 2014;78(10):1731–4.
Giordano L, Toma S, Palonta F, Teggi R, Zucconi M, Di Candia S, Bussi M. Obstructive sleep apnea in Prader-Willi syndrome: risks and advantages of adenotonsillectomy. Med Surg Pediatr. 2015;37:107.
Meyer SL, Splaingard M, Repaske DR, et al. Outcomes of adenotonsillectomy in patients with Prader-Willi syndrome. Arch Otolaryngol Head Neck Surg. 2012;138(11):1047–105.
De Marcantonio MA, Darrow DH, Gyuricsko E, et al. Obstructive sleep disorders in Prader-Willi syndrome: the role of surgery and growth hormone. Int J Pediatr Otorhinolaryngol. 2010;74:1270–2.
O’Donnell AR, Bjornson CL, Bohn SG, et al. Compliance rates in children using noninvasive continuous positive airway pressure. Sleep. 2006;29:651–8.
Koontz KL, Slifer KJ, Cataldo MD, Marcus CL. Improving pediatric compliance with positive airway pressure therapy: the impact of behavioral intervention. Sleep. 2013;26:1010–5.
Sawyer AM, Gooneratne NS, Marcus CL, et al. A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev. 2011;15(6):343–56.
Verhulst SL, Franck H, Van Gaal L, et al. The effect of weight loss on sleep disordered breathing in obese teenagers. Obesity. 2009;17(6):1178–84.
Priano L, Grugni G, Miscio G, et al. Sleep cycling alternating pattern (CAP) expression is associated with hypersomnia and GH secretory pattern in Prader-Willi syndrome. Sleep Med. 2006;7:627–33.
Clarke DJ, Waters J, Corbett JA. Adults with Prader-Willi syndrome: abnormalities of sleep and behavior. J R Soc Med. 1989;82:21–4.
Dye TJ, Jain SV, Kothare SV. Central hypersomnia. Semin Pediatr Neurol. 2015;22:93–104.
Tan HL, Urquhart DS. Respiratory complications in children with Prader-Willi syndrome. Paediatr Respir Rev. 2017;22:52–9.
Manni R, Politini L, Nobili L, et al. Hypersomnia in the Prader Willi syndrome: clinical-electrophysiological features and underlying factors. Clin Neurophysiol. 2001;112:800–5.
DeCock VC, Molinas DG, Masson VD, et al. Efficacy of modafinil on excessive daytime sleepiness in Prader-Willi syndrome. Am J Med Genet A. 2011;155A(7):1552–7.
Weselake SV, Foulds JL, Couch R, et al. Prader-Willi syndrome, excessive daytime sleepiness and narcoleptic symptoms: a case report. J Med Case Rep. 2014;8:127.
Eiholzer U. Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS. Horm Res. 2005;63:33–9.
Carrel A, Allen D, Myers S, Whitman B. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: a controlled study. J Pediatr. 1999;134:215–21.
Lindgren AC, Hagenas L, Muller J, Blichfeldt S, Rosenborg M, Brismar T, Ritzen EM. Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably. Acta Paediatr. 1998;87:28–31.
Ritzen EM, Lindgren AC, Hagenas L, Marcus C, Muller J, Blichfeldt S, Swedish Growth Hormone Advisory Group. Growth hormone treatment of patients with Prader-Willi syndrome. J Pediatr Endocrinol Metab. 1999;12:345–9.
Myers SE, Carrel AL, Whitman BY, Allen DB. Physical effects of growth hormone treatment in children with Prader-Willi syndrome. Acta Paediatr Suppl. 1999;433:112–4.
Eiholzer U, Nordmann Y, L’Allemand D. Fatal outcome of sleep apnoea in PWS during the initial phase of growth hormone treatment. A case report. Horm Res. 2002;58(Suppl3):24–6.
Nordmann Y, Eiholzer U, L’Allemand D, et al. Sudden death of an infant with Prader-Willi syndrome—not a unique case? Biol Neonate. 2002;82:139–41.
Lippe B. Safety letter. Available at: https://wayback.archive-it.org/7993/20170113164915/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm168411.htm. Accessed Jul 2017.
Deal CK, Tony M, Hoybye C, et al. GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab. 2013;98(6):E1072–87.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Whitman, B.Y., Cataletto, M.E. (2019). Prader-Willi Syndrome. In: Accardo, J. (eds) Sleep in Children with Neurodevelopmental Disabilities. Springer, Cham. https://doi.org/10.1007/978-3-319-98414-8_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-98414-8_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98412-4
Online ISBN: 978-3-319-98414-8
eBook Packages: MedicineMedicine (R0)